BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 12393646)

  • 1. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.
    Mayerhofer M; Valent P; Sperr WR; Griffin JD; Sillaber C
    Blood; 2002 Nov; 100(10):3767-75. PubMed ID: 12393646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway.
    Treins C; Giorgetti-Peraldi S; Murdaca J; Semenza GL; Van Obberghen E
    J Biol Chem; 2002 Aug; 277(31):27975-81. PubMed ID: 12032158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.
    Fukuda R; Kelly B; Semenza GL
    Cancer Res; 2003 May; 63(9):2330-4. PubMed ID: 12727858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
    Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
    Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway.
    Kim CH; Cho YS; Chun YS; Park JW; Kim MS
    Circ Res; 2002 Feb; 90(2):E25-33. PubMed ID: 11834720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
    Gao N; Nester RA; Sarkar MA
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species.
    Gao N; Ding M; Zheng JZ; Zhang Z; Leonard SS; Liu KJ; Shi X; Jiang BH
    J Biol Chem; 2002 Aug; 277(35):31963-71. PubMed ID: 12070140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite.
    Duyndam MC; Hulscher ST; van der Wall E; Pinedo HM; Boven E
    J Biol Chem; 2003 Feb; 278(9):6885-95. PubMed ID: 12482858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.
    Burchert A; Wang Y; Cai D; von Bubnoff N; Paschka P; Müller-Brüsselbach S; Ottmann OG; Duyster J; Hochhaus A; Neubauer A
    Leukemia; 2005 Oct; 19(10):1774-82. PubMed ID: 16136169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine inhibits VEGF expression in myocardial ischemia.
    Roy S; Balasubramanian S; Wang J; Chandrashekhar Y; Charboneau R; Barke R
    Surgery; 2003 Aug; 134(2):336-44. PubMed ID: 12947338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha.
    Akeno N; Robins J; Zhang M; Czyzyk-Krzeska MF; Clemens TL
    Endocrinology; 2002 Feb; 143(2):420-5. PubMed ID: 11796494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Katsaros D; Huang W; Park JW; Fracchioli S; Vezzani C; Rigault de la Longrais IA; Yao W; Rubin SC; Coukos G
    Cancer Res; 2003 Jul; 63(14):4225-31. PubMed ID: 12874030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
    J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.
    Büchler P; Reber HA; Büchler M; Shrinkante S; Büchler MW; Friess H; Semenza GL; Hines OJ
    Pancreas; 2003 Jan; 26(1):56-64. PubMed ID: 12499918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
    Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
    Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.
    Fukuda R; Hirota K; Fan F; Jung YD; Ellis LM; Semenza GL
    J Biol Chem; 2002 Oct; 277(41):38205-11. PubMed ID: 12149254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.